December 2002
Volume 43, Issue 13
Free
ARVO Annual Meeting Abstract  |   December 2002
HLA-DR Typing as a Marker of Severity of Diabetic Retinopathy
Author Affiliations & Notes
  • TB Connor
    Eye Institute Ophthalmology
    Medical College of Wisconsin Milwaukee WI
  • M Shahin
    Eye Institute Ophthalmology
    Mansoura University Mansoura Egypt
  • IM O'Shaughnessy
    Endocrinology
    Medical College of Wisconsin Milwaukee WI
  • A Hassan
    Endocrinology
    Mansoura University Mansoura Egypt
  • AH Kissebah
    Endocrinology
    Medical College of Wisconsin Milwaukee WI
  • E El-Said
    Endocrinology
    Mansoura University Mansoura Egypt
  • S Sittien
    Endocrinology
    Mansoura University Mansoura Egypt
  • H El-Serougy
    Endocrinology
    Mansoura University Mansoura Egypt
  • F El-Chennawi
    Endocrinology
    Mansoura University Mansoura Egypt
  • Footnotes
    Commercial Relationships   T.B. Connor, None; M. Shahin, None; I.M. O'Shaughnessy, None; A. Hassan, None; A.H. Kissebah, None; E. El-Said, None; S. Sittien, None; H. El-Serougy, None; F. El-Chennawi, None. Grant Identification: research to prevent blindness
Investigative Ophthalmology & Visual Science December 2002, Vol.43, 540. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      TB Connor, M Shahin, IM O'Shaughnessy, A Hassan, AH Kissebah, E El-Said, S Sittien, H El-Serougy, F El-Chennawi; HLA-DR Typing as a Marker of Severity of Diabetic Retinopathy . Invest. Ophthalmol. Vis. Sci. 2002;43(13):540.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose:Examine HLA-DR typing as a marker of severity of diabetic retinopathy Methods:350 patients from the diabetes clinc of a University Hospital were evaluated prospectively with ophthalmic exam, fluorescein angiography, Hemoglobin A1c (HbA1C), serum creatnine (Cr), HLA-DR typing, blood pressure, history, including duration of diabetes. Patients with hypertension, renal compromise (Cr ≷ 1.2), or other ophthalmic diseases were excluded. 83 patients were found to meet these criteria. Severity of diabetic retinopahty was assessed according to ETDRS grading of photographs and angiograms. Results: Patients with short duration (5.47 +/- 3.17 yrs.) and lower HbA1C (6.35+/-1.16%) with more severe retinopathy were found to have HLA-DR5 type in greater frequency (p value 0.0068). Patients with long duration (14.3 +/- 4.96 yrs) and higher HbA1c (7.01+/-1.48%) with mild diabetic retinopathy were found to have HLA-DR2 in greater frequency (p value 0.0055). Conclusion:HLA-DR5 and -DR2 typing may serve as a marker associated with severity of diabetic retinopathy.

Keywords: 388 diabetic retinopathy 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×